BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zamani M, Rahbar A, Shokri-Shirvani J. Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint. World J Gastroenterol 2017; 23(37): 6920-6922 [PMID: 29085236 DOI: 10.3748/wjg.v23.i37.6920]
URL: https://www.wjgnet.com/2150-5330/full/v23/i37/6920.htm
Number Citing Articles
1
Chao-ran Ji, Jing Liu, Yue-yue Li, Chuan-guo Guo, Jun-yan Qu, Yan Zhang, Xiuli Zuo. Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysisBMJ Open 2020; 10(10): e037375 doi: 10.1136/bmjopen-2020-037375
2
Yan Zhou, Zishao Zhong, Shengjuan Hu, Jing Wang, Yanhong Deng, Ximei Li, Xianmei Chen, Xue Li, Yuanyuan Tang, Xiaofei Li, Qian Hao, Jun Liu, Tian Sang, Yang Bo, Feihu Bai. A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China Antimicrobial Agents and Chemotherapy 2022; 66(6) doi: 10.1128/aac.02188-21
3
Xiaoman Yang, Mingjie Qian, Ying Wang, Zixin Qin, Mei Luo, Guozhong Chen, Chunrong Yi, Yao Ma, Xiaoyun Liu, Zhi Liu. Thiol-Based Modification of MarR Protein VnrR Regulates Resistance Toward Nitrofuran in Vibrio cholerae By Promoting the Expression of a Novel Nitroreductase VnrA and of NO-Detoxifying Enzyme HmpAAntioxidants & Redox Signaling 2024; 40(16-18): 926 doi: 10.1089/ars.2022.0205
4
Dong-Min Yi, Tao-Tao Yang, Shuai-Heng Chao, Ya-Xin Li, Ying-Lei Zhou, Hai-Hui Zhang, Ling Lan, Yu-Wei Zhang, Xue-Mei Wang, Yan-Rui Zhang, Jian Li, Song-Ze Ding. Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label studyMedicine 2019; 98(6): e14408 doi: 10.1097/MD.0000000000014408
5
Christina Kannigadu, David. D. N'Da. Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective DrugsCurrent Pharmaceutical Design 2020; 26(36): 4658 doi: 10.2174/1381612826666200331091853
6
Yifan Lin, Yongfu Shao, Jianing Yan, Guoliang Ye. Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practiceJournal of Clinical Laboratory Analysis 2023; 37(7) doi: 10.1002/jcla.24885
7
Catrina Olivera, Vuong Van Hung Le, Catherine Davenport, Jasna Rakonjac. In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against Gram-negative pathogens Journal of Medical Microbiology 2021; 70(3) doi: 10.1099/jmm.0.001304
8
Ying Ying Han, Ji Yan Li, Jia Lun Guan, Mei Liu, Pei Yuan Li. Application of furazolidone in Helicobacter pylori infection eradicationJournal of Digestive Diseases 2024; 25(3): 148 doi: 10.1111/1751-2980.13265
9
Elena A. Kupriyanova, Sayar R. Abdulkhakov, Ruzilya К. Ismagilova, Dilyara D. Safina, Alsu R. Akhtereeva, Raushania R. Galimova, Ayrat G. Safin, Tatiana V. Grigoryeva, Rustam А. Abdulkhakov. The prevalence of mutations underlying development of Helicobacter pylori resistance to antibiotics in KazanTerapevticheskii arkhiv 2024; 96(8): 739 doi: 10.26442/00403660.2024.08.202813
10
Yue Tong, Ruoyu Dang, Yongmei Yin, Changjun Men, Rimo Xi. A whole genome sequencing-based assay to investigate antibiotic susceptibility and strain lineage of Helicobacter pyloriMicrobial Pathogenesis 2024; 197: 107069 doi: 10.1016/j.micpath.2024.107069
11
Menizibeya Osain Welcome. Gastrointestinal Physiology2018; : 991 doi: 10.1007/978-3-319-91056-7_14
12
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza, Elvira Garza-González. Helicobacter pyloridrug resistance: therapy changes and challengesExpert Review of Gastroenterology & Hepatology 2018; 12(8): 819 doi: 10.1080/17474124.2018.1496017
13
Safiya Arfi, Prateek Sharma, Mithun Kumar, Shubham Mehra, Kunal Das, Rajashree Das, Ashwini Setya. Antibiotic susceptibility pattern of Helicobacter pylori against eight antibiotics: A study from North IndiaHelicobacter 2024; 29(3) doi: 10.1111/hel.13093
14
Jing Liu, Chao-Ran Ji, Yue-Yue Li, Chen Qiao, Jun-Nan Hu, Meng Wan, Min-Juan Lin, Bo-Shen Lin, Juan Wang, Jing Zha, Li-Xiang Li, Xiu-Li Zuo. Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot StudyClinical and Translational Gastroenterology 2021; 12(8): e00391 doi: 10.14309/ctg.0000000000000391
15
Dmitry S. Bordin, Irina N. Voynovan, Aiman S. Sarsenbaeva, Oleg V. Zaytsev, Rustam A. Abdulkhakov, Natalia V. Bakulina, Igor G. Bakulin, Marina F. Osipenko, Maria A. Livzan, Sergei A. Alekseenko. Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Terapevticheskii arkhiv 2023; 95(2): 120 doi: 10.26442/00403660.2023.02.202107
16
Jinfeng Dai, Jing Zhao, Liqi Mao, Yue Hu, Bin Lv. Study on the value of antibiotic‑resistant gene detection in Helicobacter pylori in ChinaExperimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11153
17
Peter Malfertheiner, M. Constanza Camargo, Emad El-Omar, Jyh-Ming Liou, Richard Peek, Christian Schulz, Stella I. Smith, Sebastian Suerbaum. Helicobacter pylori infectionNature Reviews Disease Primers 2023; 9(1) doi: 10.1038/s41572-023-00431-8
18
Ayush Khangai, Batsaikhan Saruuljavkhlan, Dashdorj Azzaya, Boldbaatar Gantuya, Khasag Oyuntsetseg, Junko Akada, Takashi Matsumoto, Yoshio Yamaoka. Exploring Alternative Treatment Choices for Multidrug-Resistant Clinical Strains of Helicobacter pylori in MongoliaMicroorganisms 2023; 11(12): 2852 doi: 10.3390/microorganisms11122852
19
Farnaz Rasi-Bonab, Abolfazl Jafari-Sales, Mohammad Amin Shaverdi, Tahereh Navidifar, Morteza Saki, Atosa Ghorbani, Abimbola Olumide Adekanmbi, Behboud Jafari, Sara Naebi. Antibiotic resistance pattern and frequency of cagA and vacA genes in Helicobacter pylori strains isolated from patients in Tabriz city, IranBMC Research Notes 2021; 14(1) doi: 10.1186/s13104-021-05633-5